Nektar Therapeutics (NKTR)
1.57
-0.08
(-4.85%)
USD |
NASDAQ |
May 07, 11:50
Nektar Therapeutics Market Cap: 288.28M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 302.97M |
| May 03, 2024 | 288.28M |
| May 02, 2024 | 306.64M |
| May 01, 2024 | 302.97M |
| April 30, 2024 | 268.08M |
| April 29, 2024 | 268.08M |
| April 26, 2024 | 242.38M |
| April 25, 2024 | 242.38M |
| April 24, 2024 | 253.39M |
| April 23, 2024 | 260.74M |
| April 22, 2024 | 249.72M |
| April 19, 2024 | 227.69M |
| April 18, 2024 | 242.38M |
| April 17, 2024 | 247.88M |
| April 16, 2024 | 273.59M |
| April 15, 2024 | 288.28M |
| April 12, 2024 | 306.64M |
| April 11, 2024 | 290.12M |
| April 10, 2024 | 236.87M |
| April 09, 2024 | 229.52M |
| April 08, 2024 | 240.54M |
| April 05, 2024 | 242.38M |
| April 04, 2024 | 242.38M |
| April 03, 2024 | 190.96M |
| April 02, 2024 | 174.44M |
| Date | Value |
|---|---|
| April 01, 2024 | 166.01M |
| March 28, 2024 | 171.54M |
| March 27, 2024 | 162.52M |
| March 26, 2024 | 165.26M |
| March 25, 2024 | 163.07M |
| March 22, 2024 | 167.73M |
| March 21, 2024 | 164.76M |
| March 20, 2024 | 165.26M |
| March 19, 2024 | 159.42M |
| March 18, 2024 | 156.08M |
| March 15, 2024 | 157.95M |
| March 14, 2024 | 157.91M |
| March 13, 2024 | 156.08M |
| March 12, 2024 | 163.42M |
| March 11, 2024 | 152.71M |
| March 08, 2024 | 166.93M |
| March 07, 2024 | 175.47M |
| March 06, 2024 | 167.07M |
| March 05, 2024 | 162.34M |
| March 04, 2024 | 165.26M |
| March 01, 2024 | 143.22M |
| February 29, 2024 | 130.37M |
| February 28, 2024 | 132.20M |
| February 27, 2024 | 137.71M |
| February 26, 2024 | 128.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
80.64M
Minimum
Nov 28 2023
6.346B
Maximum
Jul 03 2019
2.159B
Average
2.624B
Median
Market Cap Benchmarks
| Stereotaxis Inc | 188.90M |
| Vanda Pharmaceuticals Inc | 322.21M |
| Cara Therapeutics Inc | 42.63M |
| Avid Bioservices Inc | 538.94M |
| Rigel Pharmaceuticals Inc | 215.71M |
Market Cap Related Metrics
| PS Ratio | 3.310 |
| Price to Book Value | 2.201 |
| Price | 1.57 |
| Earnings Yield | -92.99% |